Stay updated on Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page
- Check7 days agoChange DetectedThe study record page’s previous 403 Forbidden response is replaced by a fetch error, with 0 displayed where the record content would appear.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0, while the study record page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the previous detailed study record content; navigation and site chrome remain, while the study content is not accessible on this page.SummaryDifference16%

Stay in the know with updates to Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.